Search
SOLACI Congress
HomePharmacologyOther

Other

View Category

Other

Virtual ACC 2020 | Vericiguat: New Hope in Chronic Cardiac Failure

Treatment with the new drug called Vericiguat (acting on guanosine monophosphate receptors GMP) might reduce cardiovascular mortality...
solaci -
Learn More
Other

Virtual ACC 2020 | More Evidence in Support of the Demanding 2017 Hypertension Guidelines

It’s been a while since the demanding and tough 2017 document written jointly between ACC and AHA...
solaci -
Learn More
Other

Virtual ACC 2020 | Statins Could Also Protect Against Chemotherapy Cardiotoxicity

This retrospective study has shown a reduction in hospitalization for cardiac failure in patients who were already...
solaci -
Learn More
Other

Coronavirus and the Heart: How Should Cardiologists Prepare?

As the number of confirmed cases increases throughout the globe, a picture is emerging as to what...
solaci -
Learn More
Other

Another Scandal in Evidence-Based Medicine: Ambulatory BP Monitoring Questioned?

Apparently, the scandal surrounding the EXCEL trial kicked the hornet’s nest as far as evidence-based medicine is...
solaci -
Learn More
Other

Is There a “Safe” Dose for Meat Consumption?

Meat consumption is associated with a small but significant increase in cardiovascular disease and all-cause mortality. The...
solaci -
Learn More
Other

Alcohol and Atrial Fibrillation: More Reasons for Moderate Consumption

Reducing alcohol consumption should be included in the “package” of secondary prevention recommendations, not only for its...
solaci -
Learn More
Other

New European Guidelines for Dyslipidemia Management: What is New?

Reading clinical practice guidelines, except for specific consultation, is usually tedious. These guidelines are nor meant to...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

TRILUMINATE: Liver and Kidney Failure in Tricuspid Valve Edge-to-Edge Repair

Dr. Carlos Fava - 0
Severe tricuspid regurgitation (TR) will affect roughly 3% of the 65+ population and may lead to liver and kidney failure, which will cause ascites...

Secondary Access in TAVI: Is Transradial Approach our Best Bet?

Dr. Omar Tupayachi - 0
In some countries, transcatheter aortic valve implantation (TAVI) has become the treatment of choice for patients with severe symptomatic aortic stenosis. Primary transfemoral access...

FAVOR III Europa Sub-Analysis: Coronary Revascularization Deferral Based On QFR vs FFR

Dr. Andrés Rodríguez - 0
When it comes to intermediate coronary lesion revascularization decision making, functional assessment is the recommended. At present, several indices are used, such as fractional...

Institutional News

Cuba Sessions 2025 | Young Interventional Cardiologists Contest

solaci - 0
Call for Case Submission L SOLACI Regional Sessions - 18° Central America & The Caribbean Region - It is with great pleasure that we hereby...

Hemodynamics and Interventional Cardioangiology Hybrid Training Course SOLACI-CACI

solaci - 0
We are now open for registration to the hybrid training course on Hemodynamics and Interventional Cardioangiology for Technicians and Nurses SOLACI-CACI 2025 Find all course...

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy